ALX Oncology Holdings Inc. (ALXO) Misses Q1 EPS by 6c

ALX Oncology Holdings Inc. (NASDAQ: ALXO) reported Q1 EPS of ($0.58), $0.06 worse than the analyst estimate of ($0.52).

For earnings history and earnings-related data on ALX Oncology Holdings Inc. (ALXO) click here.

You May Also Be Interested In

• Barrick Is Said to Weigh Delaying North America Gold IPO to 2027 - Bloomberg
• Yatsen Holding (YSG) Reports Q2 Loss of $0.16
• Stria Lithium rebrands as Arc Mineral Royalties after gold deal